agilon health inc. (NYSE: AGL) on September 22, 2022, started off the session at the price of $23.45, plunging -4.51% from the previous trading day. During the day, the shares moved up to $23.62 and dropped to $21.61 before settling in for the closing price of $23.51. Within the past 52 weeks, AGL’s price has moved between $14.36 and $28.76.
Top 5 Tech Stocks Every Investor Should Buy Right Now
While finding excellent stocks with the potential for gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Tech Stocks Every Investor Should Buy Right Now", we have identified five tech stocks we believe could appreciate.
Sign up here to get your free report now.
The company achieved an average annual earnings per share of -560.10%. With a float of $406.37 million, this company’s outstanding shares have now reached $407.34 million.
Let’s determine the extent of company efficiency that accounts for 648 employees.
agilon health inc. (AGL) Breakdown of a Key Holders of the stock
Observing investor behavior towards Medical Care Facilities industry stocks is more important than anything else. The insider ownership of agilon health inc. is 1.10%, while institutional ownership is 98.79%. The most recent insider transaction that took place on Sep 09, was worth 186,791. In this transaction Chief Med. & Quality Officer of this company sold 8,094 shares at a rate of $23.08, taking the stock ownership to the 10,853 shares. Before that another transaction happened on Sep 08, when Company’s Chief Med. & Quality Officer sold 13,490 for $22.66, making the entire transaction worth $305,676. This insider now owns 10,853 shares in total.
agilon health inc. (AGL) Recent Fiscal highlights
As on 3/30/2022, Multinational firm has announced its last quarter scores, in which it reported $0 earnings per share (EPS) for the period topping the consensus outlook (set at $0) by $0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -560.10% per share during the next fiscal year.
agilon health inc. (NYSE: AGL) Trading Performance Indicators
agilon health inc. (AGL) is currently performing well based on its current performance indicators. A quick ratio of 2.60 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.23.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.29, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach 0.03 in one year’s time.
Technical Analysis of agilon health inc. (AGL)
Looking closely at agilon health inc. (NYSE: AGL), its last 5-days average volume was 4.35 million, which is a jump from its year-to-date volume of 2.14 million. As of the previous 9 days, the stock’s Stochastic %D was 31.77%. Additionally, its Average True Range was 1.16.
During the past 100 days, agilon health inc.’s (AGL) raw stochastic average was set at 56.35%, which indicates a significant increase from 40.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 53.48% in the past 14 days, which was lower than the 57.58% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $23.85, while its 200-day Moving Average is $21.87. However, in the short run, agilon health inc.’s stock first resistance to watch stands at $23.51. Second resistance stands at $24.57. The third major resistance level sits at $25.52. If the price goes on to break the first support level at $21.50, it is likely to go to the next support level at $20.55. Now, if the price goes above the second support level, the third support stands at $19.49.
agilon health inc. (NYSE: AGL) Key Stats
Market capitalization of the company is 9.50 billion based on 406,731K outstanding shares. Right now, sales total 1,834 M and income totals -406,490 K. The company made 670,130 K in profit during its latest quarter, and -20,650 K in sales during its previous quarter.